"生命的子疗法"研讨会,凯恩,3月10/11,2025年-未来的战略-胰腺癌
Jean-Louis Habrand1, Siamak Haghdoost2, Semi B Harrabi3
1Radiation Oncology Department, François Baclesse Cancer Center, Caen, France.
International journal of particle therapy
|December 24, 2025
概括
重离子粒子疗法,特别是碳离子辐射疗法 (CIRT),对胰腺癌显示有前途. 专家讨论了其在先进和手术前环境中的作用,可接受的毒性,以及与其他疗法的潜在组合.
科学领域:
- 在瘤学瘤学.
- 放射疗法是一种放射治疗.
- 医学物理 医学物理
背景情况:
- 胰腺癌是癌症死亡的主要原因,需要先进的治疗策略.
- 重离子粒子疗法,特别是碳离子放射疗法 (CIRT),是一种不断发展的治疗方式.
- 国际专家召开会议,讨论CIRT的临床和生物方面的问题.
研究的目的:
- 审查重离子粒子疗法的当前指示和未来策略.
- 优先考虑CIRT在治疗胰腺癌中的作用.
- 探索CIRT与其他疗法结合的潜力.
主要方法:
- 研讨会涉及100多名国际重离子粒子治疗专家.
- 讨论CIRT的临床数据和生物学理由.
- 专注于胰腺癌治疗的先进和手术前设置.
主要成果:
- 临床数据表明,CIRT在晚期胰腺癌中起着重要作用.
- 在手术前的环境中,CIRT证明了有效性,具有可接受的毒性.
- 生物学因素支持将CIRT与生物或免疫疗法结合起来.
结论:
- 碳离子放射治疗 (CIRT) 是胰腺癌的一种有前途的治疗方法.
- CIRT为胰腺癌的先进和新辅助治疗提供了一个可行的选择.
- 未来的研究应该探索CIRT与免疫疗法和向药物的组合.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Chronic Pancreatitis II: Collaborative Care
284
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
284


